Lipid bilayer of retinal membranes

The lipid bilayer of retinal membranes is composed primarily of glycerophospholipids (phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol), cholesterol, glycolipids, and a high proportion of polyunsaturated fatty acids—most notably docosahexaenoic acid (DHA), which constitutes up to 50% of acyl chains in photoreceptor outer segment membranes[1][2][6]. The rod outer segment lipid bilayer provides a highly fluid and dynamic environment essential for the function of embedded visual transduction proteins like rhodopsin and maintains ion permeability properties critical to vision[1][2][6][7]. It is not a druggable molecular target itself but forms the biophysical context for membrane protein function, interacts with macular pigments such as lutein and zeaxanthin (influencing optical and structural properties), organizes lipid domains, and can mediate processes such as photoreceptor outer segment phagocytosis[1][2][3][6][7]. Pathological alterations in lipid composition (e.g., reduced very long chain polyunsaturated fatty acids, increased bis-retinoid adducts) are implicated in retinal aging and diseases such as age-related macular degeneration[2][4]. The lipid bilayer is a fundamental structural feature, not a specific protein, enzyme, or receptor. It is not classified as a "classic" therapeutic target; rather, therapeutic interventions may modulate membrane properties indirectly (e.g., via dietary lipids or antioxidants), but there are no drugs directly targeting the bilayer itself in the retina[7]. "Lipid bilayer of retinal membranes" is structurally and functionally crucial, but is not recognized as a molecular drug target and would generally not appear in therapeutic target lists for drug discovery or pharmacological modulation. No canonical abbreviation or indicating alias as it is not a protein or gene. While the lipid bilayer of retinal membranes is essential for retinal structure and function and contributes to disease mechanisms, it is not considered a distinct, druggable molecular target such as a receptor or enzyme[7]. Any practical future listings should clarify this and avoid treating the bilayer as a target in the conventional sense.

Other names

Retinal lipid bilayerPhotoreceptor membrane lipid bilayerRod outer segment lipid bilayer